Qiming Venture Partners has closed its fourth RMB fund at $222 million, which brings its assets-under-management to $2.7 billion. Earlier this year, Qiming closed a US-dollar fund at $650, and it now has five US-dollar and four RMB funds. Qiming, which has offices in Shanghai, Beijing, Suzhou and Hong Kong, was formed in 2006. Historically, it has invested about 40% of its capital in life science companies and had, by the beginning of 2017, invested in nearly 50 separate life science companies.
